Delve into the intriguing world of off-label medications for PTSD, with a spotlight on a new contender awaiting FDA approval. Discover promising advances in antipsychotic treatments like Brexpiprazole and its partnership with sertraline. The conversation also tackles the complexities of treating insomnia tied to PTSD, weighing the pros and cons of medications like trazodone and benzodiazepines. Personalization in treatment is emphasized as crucial for effective management.
Brexpiprazole's potential FDA approval as a PTSD treatment marks a significant shift towards more personalized pharmacological solutions in mental health care.
The mixed outcomes of topiramate for PTSD underscore the need for cautious use, particularly in treatment-resistant cases and those with substance use issues.
Deep dives
Emerging Medication Options for PTSD
A new medication, Brexpiprazole, is being considered for FDA approval as a treatment for PTSD, particularly in conjunction with sertraline for patients who do not respond to antidepressants. Trials have shown Brexpiprazole to significantly improve various PTSD symptoms including re-experiencing, avoidance, and hyperarousal, though it did not overtly address issues with sleep. Its approval could shift the landscape of PTSD treatment away from traditional antipsychotics like risperidone, which have been the go-to option. This change highlights the evolving nature of PTSD treatment and the potential for more tailored pharmacological solutions.
The Role of Topiramate in Treatment-Resistant PTSD
Topiramate was weighed as a potential treatment for PTSD, especially concerning treatment-resistant cases and co-occurring substance use issues. Initial meta-analysis indicated a promising effect size, but new data from several trials have yielded mixed outcomes, with many studies demonstrating high dropout rates due to side effects. When effective, topiramate appears better at alleviating re-experiencing symptoms rather than avoidance symptoms, suggesting it might not be suitable for all PTSD presentations. As a result, it is recommended to use topiramate cautiously and primarily in cases where other treatments have failed.
Controversy Surrounding Benzodiazepines and PTSD Therapy
The use of benzodiazepines for managing PTSD is controversial, as evidence suggests that initiating these medications shortly after trauma may increase the risk of developing PTSD. While some practitioners worry that benzodiazepines may interfere with psychotherapy, the reality is more nuanced, with mixed study results on their efficacy when taken long-term. Clinicians are often advised against starting benzos with psychotherapy but should consider the patient's history before tapering off long-term users. Given the complexities of individual cases, a balanced approach is necessary to optimize therapy while minimizing risks.
Chris Aiken and Kellie Newsome, PMHNP have disclosed no relevant financial or other interests in any commercial companies pertaining to this educational activity.
Get the Snipd podcast app
Unlock the knowledge in podcasts with the podcast player of the future.
AI-powered podcast player
Listen to all your favourite podcasts with AI-powered features
Discover highlights
Listen to the best highlights from the podcasts you love and dive into the full episode
Save any moment
Hear something you like? Tap your headphones to save it with AI-generated key takeaways
Share & Export
Send highlights to Twitter, WhatsApp or export them to Notion, Readwise & more
AI-powered podcast player
Listen to all your favourite podcasts with AI-powered features
Discover highlights
Listen to the best highlights from the podcasts you love and dive into the full episode